Home
>
901-950

901-950

Articles Published by the Ocular Immunology and Uveitis Foundation

C. Stephen Foster, M.D.

In Print (901-919)

901. Papangkorn K, Truett KR, Vitale AT, Jhaveri C, Scales DK, Foster CS, Montieth A, Higuchi JW, Brar B, Higuchi WI. Novel Dexamethasone Sodium Phosphate Treatment (DSP-Visulex) for Noninfectious Anterior Uveitis: A Randomized Phase I/II Clinical Trial. Curr Eye Res. Feb 2019.

902. Durrani K, Kempen JH, Foster CS; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group. Authors Reply to Letter to the Editor- In Response to: Comment on Durrani et al.’s “Adalimumab for Ocular Inflammation”. Ocul Immunol Inflamm. Epub 18 Oct 2017.

903. Kempen JH, Pistilli M, Begum H, Fitzgerald TD, Liesegang TL, Payal A, Zebardast N, Bhatt NP, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, for The Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study Research Group. Remission of Non-Infectious Anterior Scleritis: Incidence and Predictive Factors. Am J Ophthalmol, in press.

904. Jaffe GJ, Foster CS, Pavesio CE, Paggiarino DA, Riedel GE. Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment: Twelve-Month Results. April 2019. Vol. 126, 4; 601-610.

905. Rosenbaum JT, Bodaghi B, Couto C, Zierhut M, Acharya N, Pavesio C, Tay-Kearney ML, Neri P, Douglas K, Pathai S, Song AP, Kron M, Foster CS. New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A review. Semin Arthritis Rheum. 2019 Jun 10.

906. Long-term outcomes of systemic corticosteroid-sparing immunomodulatory therapy for Birdshot Retinochoroidopathy.

You C, Lasave AF, Kubaisi B, Syeda S, Ma L, Wai KCK, Diaz MH, Walsh M, Stephenson A, Montieth A, Foster CS.Ocul Immunol Inflamm. 2020 Aug 17;28(6):966-974. doi: 10.1080/09273948.2019.1641610. Epub 2019 Sep 30.PMID: 31567006

907. Factors Predictive of Remission of Chronic Anterior Uveitis.

Sobrin L, Pistilli M, Dreger K, Kothari S, Khachatryan N, Artornsombudh P, Pujari SS, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group.Ophthalmology. 2020 Jun;127(6):826-834. doi: 10.1016/j.ophtha.2019.11.020. Epub 2019 Nov 28.PMID: 31932091 Free PMC article.

908. COVID-19 and Immunosuppressive Therapy in Ocular Inflammatory Disease, a Telemedicine Survey.

Ebrahimiadib N, Fadakar K, Riazi-Esfahani H, Zarei M, Maleki A, Bojabadi L, Ahmadi A, Look-Why S, Foster CS.Ocul Immunol Inflamm. 2021 May 19;29(4):734-740. doi: 10.1080/09273948.2021.1949477. Epub 2021 Jul 30.PMID: 34328808

909. Tocilizumab Employment in the Treatment of Resistant Juvenile Idiopathic Arthritis Associated Uveitis.

Maleki A, Manhapra A, Asgari S, Chang PY, Foster CS, Anesi SD.Ocul Immunol Inflamm. 2021 Jan 2;29(1):14-20. doi: 10.1080/09273948.2020.1817501. Epub 2020 Oct 6.PMID: 33021415 Review.

910. The clinical and pathogenic spectrum of surgically-induced scleral necrosis: A review.

Ruiz-Lozano RE, Garza-Garza LA, Davila-Cavazos O, Foster CS, Rodriguez-Garcia A.Surv Ophthalmol. 2021 Jul-Aug;66(4):594-611. doi: 10.1016/j.survophthal.2020.12.008. Epub 2021 Jan 8.PMID: 33422510 Review.

911. Acquired Vitelliform-Like Lesion in Uveitis: A case-series.

Maleki A, Look-Why S, Asgari S, Manhapra A, Gomez S, Foster CS.Ocul Immunol Inflamm. 2022 Oct-Nov;30(7-8):2027-2036. doi: 10.1080/09273948.2021.1954201. Epub 2021 Jul 27.PMID: 34314305

912. Risk of Cataract in Intermediate Uveitis.

Minkus CL, Pistilli M, Dreger KA, Fitzgerald TD, Payal AR, Begum H, Kaçmaz RO, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Buchanich JM, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study Research Group.Am J Ophthalmol. 2021 Sep;229:200-209. doi: 10.1016/j.ajo.2021.02.032. Epub 2021 Mar 10.PMID: 33713679 Free PMC article.

913. Visual Acuity Outcome over Time in Non-Infectious Uveitis.

Pistilli M, Joffe MM, Gangaputra SS, Pujari SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Begum H, Fitzgerald TD, Dreger KA, Altaweel MM, Holbrook JT, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group.Ocul Immunol Inflamm. 2021 Aug 18;29(6):1064-1071. doi: 10.1080/09273948.2019.1687733. Epub 2019 Dec 10.PMID: 31821051 Free PMC article.

914. Treatment of Noninfectious Retinal Vasculitis Using Subcutaneous Repository Corticotropin Injection.

Anesi SD, Chang PY, Maleki A, Stephenson A, Montieth A, Filipowicz A, Syeda S, Asgari S, Walsh M, Metzinger JL, Foster CS.J Ophthalmic Vis Res. 2021 Apr 29;16(2):219-233. doi: 10.18502/jovr.v16i2.9086. eCollection 2021 Apr-Jun.PMID: 34055260 Free PMC article.

915. Clinical course and poor prognostic factors of Vogt-Koyanagi-Harada disease in a tertiary uveitis clinic.

Maleki A, Anesi SD, Look-Why S, Asgari S, Manhapra A, Foster CS.Can J Ophthalmol. 2022 Apr;57(2):142-144. doi: 10.1016/j.jcjo.2021.04.005. Epub 2021 May 10.PMID: 33984288 No abstract available.

916. B-Scan Ultrasonography Findings in Unilateral Posterior Scleritis.

Maleki A, Ruggeri M, Colombo A, Asgari S, Look-Why S, Apoorva S, Foster CS.J Curr Ophthalmol. 2022 Apr 16;34(1):93-99. doi: 10.4103/joco.joco_267_21. eCollection 2022 Jan-Mar.PMID: 35620365 Free PMC article.

917. Corneal Endothelial Transplantation in Uveitis: Incidence and Risk Factors.

Roldan AM, Zebardast N, Pistilli M, Khachatryan N, Payal A, Begum H, Artornsombudh P, Pujari SS, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Buchanich JM, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study Research Group.Am J Ophthalmol. 2022 Apr;236:288-297. doi: 10.1016/j.ajo.2021.10.031. Epub 2021 Nov 13.PMID: 34780793 Free PMC article.

918. Vascular abnormalities in uveitis.

Ebrahimiadib N, Maleki A, Fadakar K, Manhapra A, Ghassemi F, Foster CS.Surv Ophthalmol. 2021 Jul-Aug;66(4):653-667. doi: 10.1016/j.survophthal.2020.12.006. Epub 2021 Jan 5.PMID: 33412171 Review.

906. Silpa-Archa S, Sriyuttagrai W, Foster CS. Treatment for Epstein-Barr Virus-associated uveitis confirmed by polymerase chain reaction: Efficacy of Anti-Viral Agents and a literature review. J Clin Virol. 05 Jan 2022.https://pubmed.ncbi.nlm.nih.gov/35007895/

919. Intravenous tocilizumab in the treatment of resistant optic perineuritis.

Maleki A, Ramezani K, Colombo A, Foster CS.Can J Ophthalmol. 2022 Jun;57(3):e100-e103. doi: 10.1016/j.jcjo.2021.09.012. Epub 2021 Nov 3.PMID: 34742701 No abstract available.

920. Remission of Non-Infectious Anterior Scleritis: Incidence and Predictive Factors.

Kempen JH, Pistilli M, Begum H, Fitzgerald TD, Liesegang TL, Payal A, Zebardast N, Bhatt NP, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study Research Group.Am J Ophthalmol. 2021 Mar;223:377-395. doi: 10.1016/j.ajo.2019.03.024. Epub 2019 Apr 3.PMID: 30951689

907. Silpa-Archa S, Hoopholerb T, Foster CS. Appraisal of vitreous syphilis antibody as a novel biomarker for the diagnosis of syphilitic uveitis: a prospective case-control study. Eye (Lond). 16 Jan 2022.https://pubmed.ncbi.nlm.nih.gov/35034091/

921. Maleki A, Colombo A, Manhapra A, Foster CS. Dose of rituximab infusion in pediatric uveitis: Body weight versus body surface area?. Surv Ophthalmol. 4 Feb 2022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364894/

922. Ruiz-Lozano, R. E., Garza-Garza, L. A., Davila-Cavazos, O., Foster, C. S., & Rodriguez-Garcia, A. Authors’ response to: Lam D, Blah TR, Francis IC. Letter to the Editor regarding the publication: “The clinical and pathogenic spectrum of surgically-induced scleral necrosis: A review”. Survey of Ophthalmology. 6 Feb 2022. https://pubmed.ncbi.nlm.nih.gov/35139405/

923. Anesi, S. D., Chang, P. Y., Maleki, A., Manhapra, A., Look-Why, S., Asgari, S., Walsh, M., Drenen, K., & Foster, C. S. Effects of Subcutaneous Repository Corticotropin Gel Injection on Regulatory T Cell Population in Noninfectious Retinal Vasculitis. Ocular Immunology and Inflammation. 8 Mar 2022. https://pubmed.ncbi.nlm.nih.gov/35258389/

924. Maleki, A., Look-Why, S., Manhapra, A., Asgari, S., Garcia, C. M., Al-Dabbagh, A., Tsang, C., Chang, P. Y., Anesi, S. D., & Foster, C. S. Birdshot Chorioretinopathy: Resistant versus Responsive. Ocular immunology and inflammation. 30 Mar 2022. https://pubmed.ncbi.nlm.nih.gov/35353656/

925. Maleki A, Ruggeri M, Colombo A, Asgari S, Look-Why S, Apoorva S, Foster CS. B-Scan Ultrasonography Findings in Unilateral Posterior Scleritis. Journal of Current Ophthalmology. 2022 Jan-Mar. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128424/

926. Anesi, S. D., Tauber, J., Nguyen Q. D., Chang, P. Y., Berdy, G. J., Lin, C. C., Chu, D. S., Levine, H. T., Fernandez, A. D., Roy, R., Asbell, P. A., Kantor, A. M., Chang, A. T., Singh, B., Youngblood, B. A., Jeng, B. H., Jhanji, V., Rasmussen, H. S., & Foster, C. S. Lirentelimab for Severe and Chronic Forms of Allergic Conjunctivits. The Journal of Allergy and Clinical Immunology. 04 Apr 2022. https://pubmed.ncbi.nlm.nih.gov/35390403/

927. Philip AM, Anesi SD, Foster CS, Chang P. Ocular Inflammatory Complications of Treatment for Metastatic Melanoma. Ocul Immunol Inflamm. 2022 Aug. https://pubmed.ncbi.nlm.nih.gov/35914291/

928. Maleki A, Fernandez CC, Philip AM, Manhapra A, Chang PY, Foster CS. Acute macular neuroretinopathy in a patient with birdshot chorioretinopathy after intravitreal triamcinolone suspension injection. Eur J Ophthalmol. 2022 Sep. https://pubmed.ncbi.nlm.nih.gov/36062613/

929. Diagnostic and Prognostic Roles of Serum Interleukin-6 Levels in Patients with Uveitis.

Maleki A, Gomez S, Asgari S, Bosenberg Z, Manhapra A, Walsh M, Weng A, Tsang C, He C, Anesi SD, Foster CS.Ocul Immunol Inflamm. 2022 Feb 17;30(2):457-462. doi: 10.1080/09273948.2020.1815799. Epub 2020 Sep 23.PMID: 32965154

930. Silpa-Archa S, Sapthanakorn W, Foster CS. ISOLATED RETINAL VASCULITIS: Prognostic Factors and Expanding the Role of Immunosuppressive Treatment in Retinal Vasculitis Associated with Postitive QuantiFERON-TB Gold Test. Retina. 2022 Oct. https://pubmed.ncbi.nlm.nih.gov/35976249/

931. Lin M, Boonsopon S, Manhapra A, Zhao T, Foster CS. Elevated serum BAFF in patients with ocular cictricial pemphigoid. Can J Ophthalmol. 2022 Dec. https://pubmed.ncbi.nlm.nih.gov/36463967/

932. Clinical features, visual outcome, and poor prognostic factors in occlusive retinal vasculitis.

Lin M, Anesi SD, Chang PY, Eggenschwiler L, Manhapra A, Walsh M, Foster CS.Can J Ophthalmol. 2022 Jun;57(3):207-213. doi: 10.1016/j.jcjo.2021.03.001. Epub 2021 Apr 7.PMID: 33838140

933. Philip AM, Stephenson A, Al-Dabbagh A, Ramezani K, Fernandez-Santos CC, Foster CS. Ocular Cicatricial Pemphigoid With IgM-Positive Biopsy. Cornea. 11 Jan 2023. https://pubmed.ncbi.nlm.nih.gov/36728301/

934. Philip AM, Fernandez-Santos CC, Ramezani K, Dolinko AH, Manhapra A, Look-Why S, Chang PY, Foster CS, Anesi SD. Ocular Mucus Membrane Pemphigoid: A Primary Versus Secondary Entity. Cornea. 2023 Mar. https://pubmed.ncbi.nlm.nih.gov/36036657/

935. Incidence of and Risk Factors for Cataract in Anterior Uveitis.

Papaliodis GN, Rosner BA, Dreger KA, Fitzgerald TD, Artornsombudh P, Kothari S, Gangaputra SS, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Pak CM, Ying GS, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study Research Group.Am J Ophthalmol. 2023 Oct;254:221-232. doi: 10.1016/j.ajo.2023.06.021. Epub 2023 Jul 5.PMID: 37414328 Free PMC article.

936. Outcomes of IVIG monotherapy on non-paraneoplastic autoimmune retinopathy.

Zhou A, Fernández-Santos C, Dolinko A, Philip AM, Foster CS.Can J Ophthalmol. 2024 Feb;59(1):e101-e104. doi: 10.1016/j.jcjo.2023.08.001. Epub 2023 Sep 5.PMID: 37683692 No abstract available.

937. Use of immunosuppression and subsequent cancer incidence: cohort study.

Buchanich JM, Newcomb CW, Washington TL, Foster CS, Sobrin L, Thorne JE, Jabs DA, Suhler EB, Rosenbaum JT, Sen HN, Levy-Clarke GA, Nussenblatt RB, Bhatt NP, Lowder CY, Goldstein DA, Leiderman YI, Acharya NR, Holland GN, Read RW, Dunn JP, Dreger KA, Artornsombudh P, Begum HA, Fitzgerald TD, Kothari S, Payal AR, Daniel E, Gangaputra SS, Kaçmaz RO, Liesegang TL, Pujari SS, Khachatryan N, Maghsoudlou A, Suga HK, Pak CM, Helzlsouer KJ, Kempen JH.BMJ Oncol. 2023 Aug 21;2(1):e000037. doi: 10.1136/bmjonc-2023-000037. eCollection 2023.PMID: 39886503 Free PMC article.

938. Limited Clinical Value of Anti-Retinal Antibody Titers and Numbers in Autoimmune Retinopathy.

Rujkorakarn P, Margolis MJ, Morvey D, Zhou Y, Foster CS.Clin Ophthalmol. 2023 Mar 7;17:749-755. doi: 10.2147/OPTH.S404826. eCollection 2023.PMID: 36915715 Free PMC article.

939. Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality.

Kempen JH, Newcomb CW, Washington TL, Foster CS, Sobrin L, Thorne JE, Jabs DA, Suhler EB, Rosenbaum JT, Sen HN, Levy-Clarke GA, Nussenblatt RB, Bhatt NP, Lowder CY, Goldstein DA, Leiderman YI, Acharya NR, Holland GN, Read RW, Dunn JP, Dreger KA, Artornsombudh P, Begum HA, Fitzgerald TD, Kothari S, Payal AR, Daniel E, Gangaputra SS, Kaçmaz RO, Liesegang TL, Pujari SS, Khachatryan N, Maghsoudlou A, Suga HK, Pak CM, Helzlsouer KJ, Buchanich JM; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group.Ophthalmology. 2023 Dec;130(12):1258-1268. doi: 10.1016/j.ophtha.2023.07.023. Epub 2023 Jul 26.PMID: 37499954 Free PMC article.

940. Vision Outcomes of Long-Term Immunomodulatory and Steroid Therapy in Sympathetic Ophthalmia.

Zhou Y, Zhou A, Philip AM, Margolis M, Babiker F, Chang PY, Anesi SD, Foster CS.Am J Ophthalmol. 2023 Sep;253:152-159. doi: 10.1016/j.ajo.2023.05.004. Epub 2023 May 5.PMID: 37150338

941. Indications for Magnetic Resonance Imaging in Patients With Behcet Uveitis.

Borelli A, Behr J, Ruggeri M, Han M, Zhou Y, Foster CS.J Neuroophthalmol. 2024 Dec 1;44(4):473-477. doi: 10.1097/WNO.0000000000002018. Epub 2023 Oct 16.PMID: 37847219

942. Late recurrence in birdshot chorioretinopathy.

Maleki A, Look-Why S, Manhapra A, Asgari S, Philip AM, Chang PY, Anesi SD, Foster CS.Can J Ophthalmol. 2023 Apr;58(2):77-81. doi: 10.1016/j.jcjo.2021.08.006. Epub 2021 Sep 14.PMID: 34534507

943. Outcomes of Intravenous Tocilizumab Treatment for Refractory Pars Planitis.

Kongrat L, Maleki A, Rujkorakarn P, Margolis MJ, Valerio T, Massoudi Y, Anesi SD, Foster CS.Ocul Immunol Inflamm. 2024 May 23:1-6. doi: 10.1080/09273948.2024.2354751. Online ahead of print.PMID: 38781578

944. Oral cyclophosphamide treatment for clinical periocular inflammation of unknown origin.

Maleki A, Anesi SD, Chang PY, Foster CS.Oman J Ophthalmol. 2024 Oct 24;17(3):399-402. doi: 10.4103/ojo.ojo_30_24. eCollection 2024 Sep-Dec.PMID: 39651514

945. Vitamin D Supplementation and Remission from Chronic Anterior Uveitis.

Shih H, Chen Y, Huynh K, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Gangaputra SS, Payal AR, Begum H, Khachatryan N, Burnett-Bowie SM, Ying GS, Kempen JH, Sobrin L.Ocul Immunol Inflamm. 2025 May;33(4):585-588. doi: 10.1080/09273948.2024.2427857. Epub 2024 Nov 25.PMID: 39586010

946. Incidence and Remission of Post-Surgical Cystoid Macular Edema Following Cataract Surgery in Eyes With Intraocular Inflammation.

Gangaputra S, Newcomb C, Ying GS, Groth S, Fitzgerald TD, Artornsombudh P, Kothari S, Pujari SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Dreger KA, Buchanich JM, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study Research Group.Am J Ophthalmol. 2024 Nov;267:182-191. doi: 10.1016/j.ajo.2024.06.006. Epub 2024 Jun 15.PMID: 38880375

947. Effectiveness of Frequently Used TNF Inhibitors vs. Conventional Immunosuppressive Therapies for Noninfectious Uveitis.

Gangaputra SS, Newcomb CW, Ying GS, Dreger KA, Fitzgerald T, Artornsombudh P, Kothari S, Liesegang TL, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Levy-Clarke GA, Lowder CY, Goldstein DA, Holland GN, Jaffe GJ, Davis JL, Acharya NR, Latkany PA, Read RW, Garg SJ, Liederman YI, Buchanich JM, Kempen JH, For The Systemic Immunosuppressive Therapy For Eye Diseases Site Cohort Study Research Group.Ocul Immunol Inflamm. 2025 Aug;33(6):948-956. doi: 10.1080/09273948.2025.2479802. Epub 2025 Apr 15.PMID: 40233243 Free article.

948. The Rate of Failure of Trabeculectomy and Tube Shunt Surgery in Eyes with Uveitic Glaucoma and Ocular Hypertension.

Groth SL, Newcomb CW, Yang W, Payal A, Begum H, Khachatryan N, Kaçmaz RO, Dreger KA, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Levy-Clarke GA, Buchanich JM, Ying GS, Kempen JH, Gangaputra S; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study Research Group.Ophthalmol Glaucoma. 2025 May 22:S2589-4196(25)00108-5. doi: 10.1016/j.ogla.2025.05.004. Online ahead of print.PMID: 40412807 Free article.

Previous 50